Skip to content

A Study on DNAmAge in Patients with Perimenopausal Syndrome after Dietary Intervention

A Study on DNAmAge in Patients with Perimenopausal Syndrome after Dietary Intervention

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084007
Enrollment
Unknown
Registered
2024-05-09
Start date
2022-04-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perimenopausal syndrome

Interventions

Dietary interventions:Dietary intervention

Sponsors

The Affiliated Hospital of Guizhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
45 Years to 55 Years

Inclusion criteria

Inclusion criteria: age 45-55; clinical symptoms, signs, diagnosis of perimenopausal syndrome; no previous hormone supplementation therapy.

Exclusion criteria

Exclusion criteria: Patients who have used hormone replacement, traditional Chinese medicine and one year after menopause; patients with serious gynecological diseases such as hypertension, diabetes and tumors.

Design outcomes

Primary

MeasureTime frame
Improved Kupperman rating scale;MoCA Rating Scale;Gastrointestinal Symptoms ;Bristol Stool Scale;DNAmAge;fMRI;Gut Microbiota;Telomere Length;Relative Expression of Telomere Epigenetic factors;

Secondary

MeasureTime frame
The MMSE Rating Scale;

Countries

China

Contacts

Public ContactYang Lin

The Affiliated Hospital of Guizhou Medical University

1103965005@qq.com+86 139 8488 5851

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026